Segment and Geographic Information (Tables)

3 Months Ended

Mar. 31, 2026

Segment Reporting [Abstract]

Schedule of Operating Segment Reconciliation of Net Income, Including Significant Segment Expenses

The following is the Company’s operating segment reconciliation of net income, including significant segment expenses:


		Three months ended March 31,
		2026				2025
		(in thousands)
Net sales		$	66,551			$	59,871
Cost of sales			18,155				18,451
Gross profit			48,396				41,420

Less:
Selling expense			12,800				12,824
Marketing expense			1,715				1,388
Administrative expense			7,963				6,823
Finance expense			3,184				2,968
Management information systems expense			899				696
Research and development expense			1,423				1,101
Process engineering expense			1,002				739
Regulatory and clinical expense			1,635				2,255
Other (income) expense, net*			2,096				1,615
Net income		$	15,679			$	11,011

*Refer to the consolidated statement of operations for the components of other income and expense and related amounts.

Schedule of Net Sales to Unaffiliated Customers Based on Customer Location by Country

Net sales to unaffiliated customers based on customer location by country were as follows:


		Three months ended March 31,
		2026				2025
		(in thousands)
United States		$	37,186			$	34,628
Germany			5,538				3,977
Canada			4,053				3,721
United Kingdom			3,126				3,149
Other countries			16,648				14,396

Net sales		$	66,551			$	59,871